CHMP Endorses Eli Lilly’s GLP-1 Pill and Three Other New Drugs
4 Articles
4 Articles
The multinational invests 156 million to expand the capacity of its Alcobendas plant. The approval in the EU of Orforglipron is expected this year or in 2027
Forbes, the world's most renowned business and economic magazine. European Medicines Agency (EMA) indicates medicine for weight control and treatment of type 2 diabetes in adults The post Eli Lilly's Weight Loss Pill Receives EU Regulatory Body Approval apareceu primeiro em Forbes Brasil.
The EMA supports orforglipron, Eli Lilly’s daily antiobesity pill. The company will produce in Spain the drug to export to 120 countries. The entry Brussels approves orforglipron, the Lilly antiobesity pill that Spain will manufacture for 120 countries aparece primero en Merca2.
Coverage Details
Bias Distribution
- 100% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
